Author

Chao-Tsen Chen

National Taiwan University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Chen-Hsin Albert YuiD· 1 shared Grace Y.T. TaniD· 1 shared Li-Tzu ChengiD· 1 shared Pei-Yi LiniD· 1 shared Peter ChiiD· 1 shared Shih‐Han Huang· 1 shared Wendy W. Hwang‐VersluesiD· 1 shared Yu-Sheng Tsai Yuan· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chen-Hsin Albert YuORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BMAL2 is a druggable target for ARID1A-wildtype ovarian clear cell carcinoma (OCCC)

Grace Y.T. Tan, Pei-Yi Lin, Li-Tzu Cheng, Yu-Sheng Tsai Yuan, Shih‐Han Huang, Chen-Hsin Albert Yu, Chao-Tsen Chen, Peter Chi, Wendy W. Hwang‐Verslues

This study identifies BMAL2 as a therapeutic target for ARID1A-wt ovarian clear cell carcinoma, showing that its depletion or degradation reduces tumor growth and DNA damage.

bioRxiv · Oct 21, 2025 · PreprintCancer Biology